Videcef

Videcef

cefdinir

Manufacturer:

Virchow Healthcare

Distributor:

Maxxcare

Marketer:

Mega Lifesciences
Concise Prescribing Info
Contents
Cefdinir
Indications/Uses
Community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis & uncomplicated skin & skin structure infections in adults & adolescents. Acute bacterial otitis media, pharyngitis/tonsillitis & uncomplicated skin & skin structure infections in ped patients.
Dosage/Direction for Use
Adult & adolescent ≥13 yr Community-acquired pneumonia & uncomplicated skin & skin structure infections 300 mg every 12 hr for 10 days. Acute exacerbation of chronic bronchitis & pharyngitis/tonsillitis 300 mg every 12 hr for 5-10 days or 600 mg daily for 10 days. Acute maxillary sinusitis 300 mg every 12 hr for 10 days or 600 mg daily for 10 days. Adult w/ renal impairment CrCl <30 mL/min 300 mg once daily. Ped patient w/ CrCl <30 mL/min 7 mg/kg (up to 300 mg) once daily. Patient on chronic hemodialysis Initially 300 mg or 7 mg/kg every other day & at the conclusion of each session; then give subsequent dose of 300 mg or 7 mg/kg every other day.
Administration
May be taken with or without food.
Contraindications
Known allergy to cefdinir or cephalosporins.
Special Precautions
Previous hypersensitivity to cefdinir, other cephalosporins, penicillins. Cross-hypersensitivity to β-lactam antibiotics. Clostridium difficile-associated diarrhea. Prolonged treatment may result in overgrowth of resistant organisms. Individuals w/ history of colitis. Transient or persistent renal insufficiency. Pregnancy & lactation. Neonates & infants <6 mth.
Adverse Reactions
Shock, anaphylaxis, facial & laryngeal edema, feeling of suffocation, serum sickness-like reactions, conjunctivitis, stomatitis, SJS, TEN, exfoliative dermatitis, erythema multiforme & nodosum, acute & fulminant hepatitis, cholestasis, hepatic & cardiac failure, jaundice, increased amylase, acute enterocolitis, bloody diarrhea, hemorrhagic & pseudomembranous colitis, melena, pancytopenia, granulocytopenia, leukopenia, thrombocytopenia, ITP, hemolytic anemia, acute resp & renal failure, asthmatic attack (drug-induced), eosinophilic & idiopathic interstitial pneumonia, fever, disseminated intravascular coagulation, upper GI bleed, peptic ulcer, ileus, loss of consciousness, allergic vasculitis, chest pain, MI, HTN, involuntary movements & rhabdomyolysis.
Drug Interactions
Reduced absorption w/ Al- or Mg-containing antacids, Fe supplements. Inhibited renal excretion w/ probenecid.
MIMS Class
Cephalosporins
ATC Classification
J01DD15 - cefdinir ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Videcef cap 300 mg
Packing/Price
1 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in